Target Metabolic Diseases With Us

Northern Bio offers expertise in metabolic diseases to accelerate the development and evaluation of your therapeutic.

Preclinical Expertise in Metabolic Disease

Northern Bio offers services to support the development of therapeutics for the treatment of metabolic diseases. This may be inclusive of diabetes and diet-induced obesity, amongst others. By leveraging state-of-the-art imaging and biomarker assessment and utilizing specified preclinical approaches, Northern Bio is able to accelerate programs from concept to regulatory approval.

Consult a Scientist

We are a team of scientists who value open communication and collaboration. We work closely with our sponsors to provide customized solutions and expert support.

Targeted Delivery

Northern Bio supports the development of diverse therapeutic modalities, including stem cells, biologics, gene therapies (AAVs), RNA-based treatments, and small molecules. Targeted delivery approaches, such as pancreatic duct delivery and standard intravascular infusion approaches to assess toxicological and efficacious effects, promote better patient outcomes.

Instrumentation & Capabilities

Equipment

MRI – Philips 3T
Philips Intellispace Image Analysis
2 GE OEC9900 Cardiac Fluoroscope
Philips CVx ultrasound
Endoscopic equipment

Metabolic Models

Type 1 Diabetes – chemically induced
Type 2 Diabetes
Diet-Induced Obesity

Routes of Administration

Direct Pancreatic Duct
All parenteral Routes (IV, IM, PO, SC)

Species

Mouse
Rat
NHP
Swine

Partner With Us

Let’s work together to develop
life-changing treatments.

Join us in the pursuit of better lives through scientific innovation. Explore how Northern Bio can help you achieve your research goals.